Eucrates Biomedical Acquisition Corp. (EUCR)

followers · Follow

Sector:

FINANCE

Industry:

CORPORATE FINANCE

SIC:

BLANK CHECKS

CEO:

Parag P. Saxena

Employees:

250 WEST 55TH STREET, SUITE 13D, NEW YORK, NY, 10019

(212) 710-5220

N/A

Are you looking for this stock instead?

WISDOMTREE EURO DEBT FD CREATION

Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Eucrates Biomedical Acquisition Corp. YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available